Richwood Investment Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Richwood Investment Advisors's BMY Position: Q2 2026 in Review
Richwood Investment Advisors increased its Bristol-Myers Squibb (BMY) stake by 6.7% in Q2 2026, buying an estimated $41.1K and bringing the position to 11,312 shares worth $652K. The position accounts for 0.46% of the portfolio, ranked #54.
Richwood Investment Advisors first reported a position in BMY in Q4 2021 and has held it in 19 quarters since. The position peaked at $1.18M in Q2 2022. 2,521 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Richwood Investment Advisors held 11,312 shares of Bristol-Myers Squibb worth $652K as of Q2 2026.
- Richwood Investment Advisors bought 715 Bristol-Myers Squibb shares in Q2 2026, an estimated $41.1K.
- Bristol-Myers Squibb made up 0.46% of Richwood Investment Advisors's portfolio in Q2 2026, its #54 holding.
- Richwood Investment Advisors first reported a position in Bristol-Myers Squibb in Q4 2021 and has held it in 19 quarters since.
- Richwood Investment Advisors's Bristol-Myers Squibb position peaked at $1.18M in Q2 2022.
- 2,521 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Richwood Investment Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.